https://www.avient.com/sites/default/files/2022-05/ColorMatrix Amosorb Solo Technical Bulletin.pdf
Figure 1.
Picture of plaques originally made from preforms containing Fortis Amber-1 and Amosorb Solo2-2.
BOTTLE COMPOSITION L* a* b* 95.91% Virgin PET/0.09% Fortis Amber-1/4% SolO2-2 76.9 3.6 39.5 50% Regrind/50% Virgin PET 83.5 2.8 19.5 50% Regrind/50% Virgin PET/0.045% Fortis Amber-1 75.6 5.5 34.5 RESULTS FOR RE-GRIND COMBINATION STUDY CONCLUSIONS Our study has shown that the combined use of Amosorb SolO2-2 and Fortis-Amber 1 in bottle applications allows for the material to be recycled through multiple recycle loops.
https://www.avient.com/sites/default/files/2020-09/stat-tech-tri-fold-processing-guide.pdf
Base Resin PC PC/PSU PES PEI PP ABS PEEK PA Barrel Temperatures* °F (°C) Rear Zone 530–560 (277–293) 550–575 (288–302) 660–700 (349–371) 675–725 (357–385) 390–420 (199–216) 425–460 (219–238) 680–730 (360–388) 430–500 (221–260) Center Zone 515–560 (269–288) 540–565 (282–296) 650–690 (343–366) 655–710 (352–377) 380–405 (193–207) 415–450 (213–232) 670–710 (354–377) 420–490 (216–254) Front Zone 510–525 (266–274) 530–555 (277–291) 640–680 (338–360) 655–700 (346–371) 370–395 (188–202) 405–440 (207–227) 650–690 (343–366) 410–480 (210–249) Nozzle 520–535 (271–280) 540–565 (282–296) 650–690 (343–366) 665–710 (352–377) 380–400 (193–204) 415–450 (213–232) 660–700 (349–371) 420–490 (216–254) Melt Temperature 525–560 (274–293) 530–580 (277–304) 650–700 (343–371) 660–730 (349–388) 375–395 (191–202) 410–460 (210–238) 650–730 (343–388) 420–500 (216–260) Mold Temperature 175–250 (80–121) 160–220 (71–104) 280–350 (138–177) 275–350 (135–177) 100–135 (38–57) 150–180 (66–82) 300–425 (149–219) 160–230 (71–110) Pack & Hold Pressure 50%–75% of Injection Pressure Injection Velocity in/s 0.5–2.0 Back Pressure psi 50 Screw Speed rpm 40–70 40–70 40–70 40–70 40–70 40–70 40–70 40–70** Drying Parameters °F (°C) 6 hrs @ 250 (121) 4 hrs @ 250 (121) 4 hrs @ 275 (135) 4 hrs @ 250 (121) 3 hrs @ 300 (150) 2 hrs @ 200 (93) 3 hrs @ 275 (135) 4 hrs @ 180 (82) Cushion in 0.125–0.250 Screw Compression Ratio 2.0:1–2.5:1 2.0:1–2.5:1 2.5:1–3.5:1 2.5:1–3.5:1 2.5:1–3.5:1 2.5:1–3.5:1 2.5:1–3.5:1 2.5:1–3.5:1 Nozzle Type General Purpose General Purpose General Purpose General Purpose General Purpose General Purpose General Purpose Reverse Taper Clamp Pressure 5–6 Tons/in2 * A reverse temperature profile is important to obtain optimum conductive properties.
Half-round runners are not recommended. • Only naturally balanced runner systems (“H” pattern) are recommended. • Runner diameters larger than 0.150" (3.8mm) and not exceeding 0.375" (9.5mm) are recommended. • Step each 90° bend in the system down in size (from sprue to gate) approximately 1/16" (1.5mm) to reduce pressure drop. • Place vents at each 90° intersection and vent to atmosphere. • Hot runner molds are acceptable and should be sized by the manufacturer.
Draft Angle • Maintain a minimum draft angle of 1/2° per side.
https://www.avient.com/sites/default/files/2021-12/avient-sarl-hungary-branch-register-extract-2021-12-07.pdf
Data not dependent on company form 1.
Tax number of the company 21/1.
Company numbers 49/1.
https://www.avient.com/sites/default/files/resources/TRA%2520-%25202016%2520Annual%2520Report%2520for%252015%2520Tideman.pdf
lang=En&n=3C401D5C-1 http://www.ec.gc.ca/default.asp?
lang=En&n=BD3CE17D-1 http://www.ec.gc.ca/default.asp?
n=29E6BF9F-1&lang=en http://www.ec.gc.ca/default.asp?
https://www.avient.com/sites/default/files/2025-03/Q4 2024 Avient Webcast Slides w Non-GAAP.pdf
All Rights Reserved 2025 4 Full-year 2024 organic revenue growth - by region ▲5% ▲1% ▲5% ▲15% Year-over-year revenue growth, excludes the impact of foreign exchange US & Canada Europe, Middle East & Africa Asia Latin America 5Copyright © .
All Rights Reserved 2025 Color, Additives & Inks END MARKETS REGIONS 34% 21% 15% 11% 9% 8% Packaging Telecom 1%Energy 1% Transportation Industrial Consumer 34% 37% 20% 9% US & Canada Latin America Asia Europe, Middle East and Africa Healthcare Building & Construction 21Copyright © .
All Rights Reserved 2025 22 Avient 2024 regional sales, by end market US & CANADA 41% of sales EMEA 35% of sales ASIA 18% of sales LATIN AMERICA 6% of sales 13% 22% 14% 9% 13% 10% 9% 6% 4% Packaging TelecomEnergyDefenseHealthcareBuilding & construction TransportationIndustrialConsumer 26% 13% 16% 13% 10% 5% 10% 5% 2% 31% 26% 14% 10% 5% 10% 1%1% 2% 61% 20% 7% 6% 4% 2% Copyright © .
https://www.avient.com/sites/default/files/2021-03/avient-march-ir-fermium_0.pdf
Microsoft PowerPoint - Avient March IR - Fermium AVIENT CORPORATION (NYSE: AVNT) M A R C H 1 8 , 2 0 2 1 I R M E E T I N G S H O S T E D B Y F E R M I U M R E S E A R C H DISCLAIMER 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
We are Avient. 4 BETTER TOGETHER: POLYONE AND CLARIANT MASTERBATCH Key Financial Data (1) 2021E Sales $4.1 billion 2021E EBITDA $510 million 2021E Free Cash Flow $250 million 87% of EBITDA from specialty applications (1) As of February 9, 2021 webcast Innovation is the lifeblood of a specialty company.
Purchase price multiple rapidly declining on strength of business and synergy capture (1) (1) (1) (1) (1) (1) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition ($ in millions) 12 SEM CAI Avient • Composites and Outdoor High Performance applications drove positive mix within SEM • Clariant Masterbatch synergy realization under way and expected to drive further margin expansion in 2021 • Portfolio transformation to high growth end markets with focus on sustainable solutions megatrend (1) EBITDA MARGIN EXPANSION Distribution 15.2% 17.6% 11.1% 12.1% 6.4% 6.3% 15.2% 16.2% (2) (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition (2) Total company reflects adjusted EBITDA margins SPOTLIGHT: COMPOSITES 13 • SEM delivers a record year in 2020 – 13% operating income growth and over 200 bps in margin expansion year-over-year • Prior investments in composites platform and outdoor high performance applications paying off, resulting in substantial growth over the last two years SEM Operating Income (OI % of Sales) ($ in millions) $(0.1) $(1.0) $2.2 $19.1 $26.8 2016 2017 2018 2019 2020 Composites Performance (Operating Income) $83.7 $94.4 2019 2020 (11.2%) (13.3%) 0.1 0.1 0.2 0.5 0.6 0.7 0.8 0.9 0.9 1.0 11 12 13 14 15 16 17 18 19 20 $19 $160 $338 2011 2019 2020 0.16 0.20 0.26 0.34 0.42 0.50 0.58 0.72 0.79 0.81 0.85 11 12 13 14 15 16 17 18 19 20 21E FREE CASH FLOW AND CAPITAL ALLOCATION 14 Free Cash Flow Dividends Share Repurchases Deleveraging 3.5x 2.7x 2019PF 2020PF Growing Dividend Cumulative Buybacks Net Leverage $B n $ p e r sh ar e Cash Generation (1) (1) ~$1Bn REPURCHASED OVER LAST 10 YEARS ~$350MM PAID OVER LAST 10 YEARS ~$338MM 2.7x NET LEVERAGE (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition GREAT PLACE TO WORK!
https://www.avient.com/sites/default/files/2020-12/resound-om-technical-bulletin_0.pdf
TECHNICAL BULLETIN UV RESISTANCE • UV testing: QUV-A Test, 0.68 @ 45C • Comparable results to traditional TPEs reSound OM 5510-45N reSound OM 5510-60N Bio-derived Content (%) 40% 50% Hardness, Shore A 45 60 Delta E after 150 hrs. 0.22 0.23 Delta E after 300 hrs. 1.68 0.56 AGING – BONDING STRENGTH ONTO ABS reSound OM 5520-55N Room Temperature 70C 1 day 1 week 2 weeks 6 months 1 week 2 weeks 3 weeks Bio-derived Content (%) 49% 49% 49% 49% 49% 49% 49% Hardness, Shore A 54 54 55 54 55 56 OM Substrate ABS ABS ABS ABS ABS ABS ABS OM Avg.
Peel, PLI 12 19 23 20 19 reSound OM 5510 for PP reSound OM 5510-60N Room Temperature 70C 1 day 1 week 2 weeks 6 months 1 week 2 weeks 3 weeks Bio-derived Content (%) 50% 50% 50% 50% 50% 50% 50% Hardness, Shore A 60 60 60 60 60 60 60 Specific Gravity 0.89 0.89 0.89 0.89 0.89 0.89 0.90 50% Modulus, PSI 247 241 244 251 234 244 240 100% Modulus, PSI 343 333 338 339 321 331 326 Tensile Strength, PSI 625 621 647 610 633 662 642 Elongation, % 306 314 309 313 312 315 315 Tear Strength, PLI 109 108 113 113 111 117 115 reSound OM 5520-55N Room Temperature 70C 1 day 1 week 2 weeks 6 months 1 week 2 weeks 3 weeks Bio-derived Content (%) 49% 49% 49% 49% 49% 49% 49% Hardness, Shore A 54 54 55 55 54 55 56 Specific Gravity 0.95 0.95 0.96 0.96 0.95 0.96 0.96 50% Modulus, PSI 258 256 256 265 266 271 257 100% Modulus, PSI 353 355 357 362 373 379 367 Tensile strength, PSI 637 615 637 669 651 674 642 Elongation, % 319 315 319 333 313 319 315 Tear Strength, PLI 146 136 133 142 137 138 141 reSound OM 5510-45N Room Temperature 70C 1 day 1 week 2 weeks 6 months 1 week 2 weeks 3 weeks Bio-derived Content (%) 40% 40% 40% 40% 40% 40% 40% Hardness, Shore A 45 46 47 46 46 45 45 Specific Gravity 0.88 0.89 0.89 0.89 0.89 0.89 0.90 50% Modulus, PSI 153 158 154 162 137 136 133 100% Modulus, PSI 251 259 259 261 226 222 218 Tensile Strength, PSI 438 481 451 495 417 470 486 Elongation, % 215 240 211 243 204 227 238 Tear Strength, PLI 84 81 87 82 83 85 84 AGING – PROPERTY RETENTION • Tested at room temperature and 70° C for comparison • Hardness, tensile strength elongation and modulus showed great retention Overmolding onto PP Overmolding onto ABS RHEOLOGY Suitable for injection molding and overmolding 1.0 10 100 1000 10000 100000 10.0 100.0 1000.0 reSound OM 5510-30N reSound OM 5510-45N reSound OM 5510-60N reSound OM 5510-70N Shear Rate, 1/s Ca pi lla ry V is co si ty , P a* s 1.0 10 100 1000 10000 100000 10.0 100.0 1000.0 reSound OM 5520-55N Shear Rate, 1/s Ca pi lla ry V is co si ty , P a* s Capillary viscosity at 200°C Capillary viscosity at 200°C reSound OM 5510 for PP reSound OM 5520 for ABS www.avient.com Copyright © 2020, Avient Corporation.
https://www.avient.com/sites/default/files/2025-03/380605_AVIENT_2024AR_full_250325.pdf
Sequeira Vice President, Chief Information Officer Leadership Committees 1.
Committees: 1, 2 Gregory J.
Committees: 1, 4 Kim Ann Mink, Ph.D.
https://www.avient.com/sites/default/files/2022-03/CESA Extend Product Selector Guide.pdf
CESA™ Extend Additives Chain Extension CESA EXTEND – STANDARD OFFERINGS PRODUCT SELECTION GUIDE POLYMER FAMILY MATERIAL PRODUCT NAME PRODUCT TYPE DOSAGE Nylon ABA0698501 CESA Extend 78501L Linear 1–6% Nylon ABA0698502 CESA Extend 78502X Branched 1–6% Polyester NBA0698490 CESA Extend 58490 Linear 1–6% Polyester NBA0820023 CESA Extend NBA0820023 Branched 1–6% Polycarbonate NCA0820004 CESA Extend 90032 Linear 1–6% Polycarbonate NCA0820005 CESA Extend 90033 Branched 1–6% TPU RUA0698460 CESA Extend 88460 Linear 1–6% TPU RUA0698455 CESA Extend 88455 Branched 1–6% CESA Extend additives can be used in combination with other CESA masterbatches, and formulations can be customized for most applications.
https://www.avient.com/sites/default/files/2023-02/AVNT Q4 2022 Earnings Presentation.pdf
Pro Forma Financial Information The Company acquired Avient Protective Materials (“Dyneema”) on September 1, 2022 (the “Acquisition Date”) and sold the Distribution segment on November 1, 2022.
EBITDA Margins (1) 5.4% 11.5% 16.2% 2006 2018 2022PF $142 $408 $592 2006 2018 2022PF 2006 figures exclude joint venture results 2022 pro forma for the acquisition of Avient Protective Materials Adj.
Three Months Ended December 31, 2022 2021 Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1) Net (loss) income from continuing operations attributable to Avient shareholders $ (17.0) $ (0.19) $ 11.2 $ 0.12 Special items, after tax (Attachment 3) 38.3 0.42 23.9 0.26 Amortization expense, after-tax 14.6 0.16 11.3 0.12 Adjusted net income / EPS $ 35.9 $ 0.39 $ 46.4 $ 0.50 Year Ended December 31, 2022 2021 Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1) Net income from continuing operations attributable to Avient shareholders $ 82.8 $ 0.90 $ 151.8 $ 1.65 Special items, after tax (Attachment 3) 116.2 1.26 50.0 0.54 Amortization expense, after-tax 49.0 0.53 44.9 0.49 Adjusted net income / EPS $ 248.0 $ 2.69 $ 246.7 $ 2.68 (1) Per share amounts may not recalculate from figures presented herein due to rounding 1 Three Months Ended December 31, Year Ended December 31, Reconciliation to EBITDA and Adjusted EBITDA 2022 2021 2022 2021 Net (loss) income from continuing operations – GAAP $ (16.6) $ 10.3 $ 83.1 $ 151.6 Income tax (benefit) expense (60.8) 17.1 (19.3) 51.9 Interest expense 49.4 17.5 119.8 75.2 Depreciation and amortization from continuing operations 48.6 38.0 162.5 145.1 EBITDA $ 20.6 $ 82.9 $ 346.1 $ 423.8 Special items, before income tax 104.3 20.5 194.0 57.1 Interest expense included in special items (16.0) — (26.0) — Depreciation and amortization included in special items (1.5) (1.6) (5.5) (1.7) APM pro forma adjustments - 2021 — 30.4 — 120.5 APM pro forma adjustments - 8 months 2022* — — 83.1 — Adjusted EBITDA $ 107.4 $ 132.2 $ 591.7 $ 599.7 * Pro forma adjustment for January - August 2022 APM results (period before Avient ownership).